Pharma IPO Alert: Onyx Biotec Raising ₹29.34 Cr – Apply or Avoid? | Onyx Biotec IPO Review
Onyx Biotec IPO opens for subscription on November 13, 2024 and closes on November 18, 2024. Is it worth investing your money in this Pharma IPO? In this Onyx Biotec IPO review we will answer this question for you. This Onyx Biotec IPO analysis covers important points like company's business model, financials, clientele, valuation and more! Subscribe for more SME IPO reviews like this!
About Onyx Biotec Limited:
Onyx Biotec Limited is a pharmaceutical company specializing in sterile pharmaceutical products, including sterile water for injections, dry powder injections, and dry syrups. Established in 2005, the company operates two WHO-GMP certified manufacturing facilities in Himachal Pradesh, India. It serves as a contract manufacturer, offering comprehensive product development and manufacturing solutions to clients in India and overseas. Onyx Biotec has a strong focus on quality and compliance, holding ISO certifications for quality and environmental management systems.
Additional Onyx Biotec IPO Details:
Onyx Biotec IPO price band is set at ₹58 to ₹61 per share. The minimum lot size for an application is 2000 Shares. The minimum amount of investment required by retail investors is ₹122,000. The minimum lot size investment for HNI is 2 lots (4,000 shares) amounting to ₹244,000.
Join Us For all the latest updates about startups, preipo and unicorns.
Keep yourself updated with the market situation.
Join us on Facebook
Contact us at +91 7065560002 via Whatsapp/Normal call
Or Mail us athelp@planify.in
Download the app for easy access. Links are given below: